In Europe , surgeons can keep donor hearts and lungs `` alive '' during transport . The company then hopes to submit their device to the U.S. Food and Drug Administration for approval . They are then transplanted into a new body with the same organs as their original one. Scientists hope to increase donor pool , improve patient outcomes .
In Europe , surgeons can keep donor hearts and lungs `` alive '' during transport . They are then transplanted into a new body with the same organs as their original one. Scientists hope to increase donor pool , improve patient outcomes .